[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f3fhw16hy7nwxl":3,"organisation-cd6a15a8-a62e-4b79-ad74-dd43ce135544":5,"organisation-articles-cd6a15a8-a62e-4b79-ad74-dd43ce135544":11},{"hasError":4,"data":5},false,{"id":6,"title":7,"color":8,"path":9,"logoUrl":10},"cd6a15a8-a62e-4b79-ad74-dd43ce135544","Bijl PR B.V.","","bijlpr","https:\u002F\u002Forder.perssupport.nl\u002Ffile\u002Flogos\u002Fcd6a15a8-a62e-4b79-ad74-dd43ce135544\u002F078a8aa9-eb68-40ea-88ca-c4c694bde8d2.jpg",[12,22,32,40,49],{"id":13,"title":14,"pubDate":15,"logoUrl":16,"thirdParty":4,"orgId":6,"branches":17,"description":21},"6c6184da-d498-4152-9377-70d58eef2253","1 op de 3 Nederlanders met diabetes overwoog hobby op te geven na diagnose","2024-11-14T08:30:11.618+01:00","https:\u002F\u002Fwww.persberichten.nl\u002Ffile\u002Flogos\u002Fcd6a15a8-a62e-4b79-ad74-dd43ce135544\u002F078a8aa9-eb68-40ea-88ca-c4c694bde8d2.jpg",[18],{"id":19,"title":20},"29100","Zorg","Dexcom onthult nieuw wereldwijd onderzoek die de impact onthullen die technologie heeft op het mogelijk maken van mensen met alle soorten diabetes om hun dromen",{"id":23,"title":24,"pubDate":25,"logoUrl":16,"thirdParty":4,"imageUrls":26,"orgId":6,"branches":29,"description":31},"54161550-b74d-4b3d-812d-e8aab83a2cc8","Doorbraak in Diabeteszorg","2024-10-07T07:30:00.058+02:00",[27,28],"https:\u002F\u002Flh3.googleusercontent.com\u002FDUfFM_G6W46u4LGKWDTrOVEMfSkYE9fVNaAw1Le9IW5SE_7Qzmw7tbDS8tMZCxFAcPuwKCOyRf3RA5dHJfe3k_H8fxXejuleMg","https:\u002F\u002Flh3.googleusercontent.com\u002FMPvp_NsMIJ2Uc3HwelEwGwMz25uELaaEyKfW9QFMsIo8vB9kVlRqWx9e1GCQvnxTHLhtR-DKtnpUbWrh3ihXGnHFRx-27fOJ",[30],{"id":19,"title":20},"Zilveren Kruis\u002FAchmea ziet waarde van real-time CGM-technologie en Zorginstituut Nederland actualiseert advies aan zorgverzekeraars Real-Time Continue Glucose M",{"id":33,"title":34,"pubDate":35,"logoUrl":16,"thirdParty":4,"imageUrls":36,"orgId":6,"branches":37,"description":39},"68a86909-7d37-490c-82f9-c69693af6efc","Dexcom G7: eerste glucosesensor met directe Apple Watch-verbinding in Nederland","2024-09-02T15:00:00.040+02:00",[27,28],[38],{"id":19,"title":20},"Dexcom G7 is het eerste en enige systeem voor continue glucosemonitoring dat rechtstreeks verbinding maakt met de Apple Watch*. Dexcom G7 geeft gebruikers de vr",{"id":41,"title":42,"pubDate":43,"logoUrl":16,"thirdParty":4,"imageUrls":44,"orgId":6,"branches":46,"description":48},"5925de84-aa18-4688-abc3-edb1225ff9cd","Meer vrijheid voor mensen met diabetes dankzij nieuw hybrid closed loop systeem ","2024-06-20T13:09:30.228+02:00",[45],"https:\u002F\u002Flh3.googleusercontent.com\u002F-B0_sBDwDY8_EWhkqONZPF0p4H_uoTLLVK68eCrqiATGBqgyLJo3mhXrR3BYoF1Zme8S72Txlx9UJi_pHN5IZ-XSqnvwEWBu",[47],{"id":19,"title":20},"In Nederland hebben 100.000 mensen diabetes type 1, waarvan naar schatting 10.000 kinderen*. Dit maakt de ziekte na astma de meest voorkomende auto-immuunziekte",{"id":50,"title":51,"pubDate":52,"logoUrl":16,"thirdParty":4,"imageUrls":53,"orgId":6,"branches":55,"description":59},"5574f786-f2e6-4ea4-b2e8-565c8e239111","Dexcom biedt mensen met diabetes meer vrijheid door nieuw Hybrid Closed Loop partnerschap","2024-06-20T13:08:15.716+02:00",[54],"https:\u002F\u002Flh3.googleusercontent.com\u002FVq0DJvsoUbP0rK1d1XCj_7kVoqHCvDhF83UYvrNUvfL5KW1j9C17CRAZyM2AXB9bECtATKzTg7YsduADTN30k3RmQDGBU3yr5s8",[56],{"id":57,"title":58},"26100","Economie en geld","DexCom, Inc. (Nasdaq: DXCM), een wereldleider in continue glucosemonitoring voor mensen met diabetes, kondigt vandaag aan dat mensen met diabetes type 1 in Nede"]